Email this article to a friend
NF-κB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor
-
* Corresponding author: Tetsuo Kubota tetsuo.kubota.mtec@tmd.ac.jp
Arthritis Research & Therapy 2007, 9:R97 doi:10.1186/ar2298